Bringing New Options for Cancer Treatment: Market Development for Cancer Gene Panel Testing
“I want to bring new hope to patients fighting cancer.”
Have you heard of the new test called "Cancer Gene Panel Testing"? First covered by national insurance in Japan in 2019, this testing enables "precision medicine" based on each patient's genetic information, offering new options in cancer treatment.
An employee at Sysmex, responsible for market development for the cancer gene panel testing in Japan, speaks about the potential of this testing and shares her mission and determination to bring new hope to cancer patients.
